OCON’s Pioneering IUB™ Ballerine® Femtech Applauded by Frost & Sullivan
April 23, 2021
Frost & Sullivan recognizes OCON Healthcare (OCON) with the 2021 Global Enabling Technology Leadership Award for creating the world’s first and only 3D spherical copper IUD, the Intra Uterine Ball (IUB)™ Ballerine®.
Femtech startup OCON Healthcare announces last patient in phase IIa clinical study, evaluating its intrauterine drug delivery platform IUB™ SEAD™, a non-invasive treatment for abnormal uterine bleeding (AUB)
March 10, 2021
The trial assesses the safety and efficacy of the IUB™ SEAD™, a disruptive treatment for AUB. In this study, 50% of the participating patients have reached the End of the Study point, demonstrating a significant reduction in bleeding, avoiding the need to undergo invasive uterine ablation procedures or even a hysterectomy
OCON CEO Keren Leshem is featured on Forbes as one of the three women shaping the world of women’s health
January 21, 2021
These 3 Women Are Shaping The Future Of Women’s Health By Bringing Next Generation Of FemTech Products To The Market.
It’s not a secret that finally, after years of being overlooked, women’s health is having its moment.
IUB, OCON and the OCON and IUB logos are trademarks of OCON Medical Ltd. Ballerine and Sphera are registered trademarks of OCON Medical Ltd. OCON products are not yet approved for sale in the United States. IUB Ballerine MAXI: CE mark pending. Copyright OCON Medical Ltd., d/b/a OCON Healthcare.